Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids

Connexin43 mimetic peptide (Cx43MP) has been intensively investigated for its therapeutic effect in the management of inflammatory eye conditions, spinal cord injury, wound healing and ischemia-induced brain damage. Here, we report on a validated stability–indicating reversed-phase high performance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisht, Rohit, Rupenthal, Ilva D., Sreebhavan, Sreevalsan, Jaiswal, Jagdish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790747/
https://www.ncbi.nlm.nih.gov/pubmed/29404061
http://dx.doi.org/10.1016/j.jpha.2017.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790747/
https://www.ncbi.nlm.nih.gov/pubmed/29404061
http://dx.doi.org/10.1016/j.jpha.2017.06.008

Ejemplares similares